Challenges in detecting and predicting adverse drug events via distributed analysis of electronic health record data from German university hospitals

Challenges in detecting and predicting adverse drug events via distributed analysis of electronic health record data from German university hospitals

Show other versions (1)

Saved in:

Bibliographic Details
Main Authors:	Anna Maria Wermund, Torsten Thalheim, André Medek, Florian Schmidt, Thomas Peschel, Alexander Strübing, Daniel Neumann, André Scherag, Markus Loeffler, Miriam Kesselmeier, Ulrich Jaehde
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2025-06-01
Series:	PLOS Digital Health
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12200832/?tool=EBI
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Challenges in detecting and predicting adverse drug events via distributed analysis of electronic health record data from German university hospitals.
by: Anna Maria Wermund, et al.
Published: (2025-06-01)

Internet-based cognitive-behavioural writing therapy for reducing post-traumatic stress after severe sepsis in patients and their spouses (REPAIR): results of a randomised-controlled trial
by: André Scherag, et al.
Published: (2022-03-01)

Leveraging Interoperable Electronic Health Record (EHR) Data for Distributed Analyses in Clinical Research: Technical Implementation Report of the HELP Study
by: Julia Palm, et al.
Published: (2025-07-01)

Protocol for implementation of intraoperative adverse event recording during WHO checklist sign-out
by: Guy Haller, et al.
Published: (2025-05-01)

Quality of the record of drug-related problems in a database for voluntary adverse event reporting
by: Maria Teresa Aznar-Saliente, et al.
Published: (2017-07-01)

How machine learning on real world clinical data improves adverse event recording for endoscopy
by: Stefan Wittlinger, et al.
Published: (2025-07-01)

High risk for life-threatening adverse events of fluoroquinolones in young adults: a large German population-based cohort study
by: Julia Wicherski, et al.
Published: (2025-02-01)

Minor Adverse Events Postcolonoscopy
by: Catherine Dubé
Published: (2014-01-01)

Safety of creatine supplementation: Analysis of Adverse Events reported in clinical trials and adverse event reports
by: Sarah E. Johnson, et al.
Published: (2025-09-01)

Analysis of postmarketing neuropsychiatric adverse events of avapritinib based on the FDA adverse event reporting system
by: Wei Mao, et al.
Published: (2025-01-01)

Comprehensive analysis of adverse events associated with vortioxetine using the FDA adverse event reporting system
by: Liangxia Li, et al.
Published: (2025-05-01)

Pretrained patient trajectories for adverse drug event prediction using common data model-based electronic health records
by: Junmo Kim, et al.
Published: (2025-06-01)

Nature of adverse events with opioids in hospitalised patients: a post-hoc analysis of three patient record review studies
by: Martine de Bruijne, et al.
Published: (2020-09-01)

Adverse events associated with amlodipine: a pharmacovigilance study using the FDA adverse event reporting system
by: Jiazhen Jiang, et al.
Published: (2025-05-01)

Musculoskeletal adverse events reported post-hepatitis B vaccination in the vaccine adverse event reporting system
by: Yiqing Sun, et al.
Published: (2025-05-01)

Adverse events associated with gepants: a pharmacovigilance analysis based on the FDA adverse event reporting system
by: Qi Song, et al.
Published: (2025-06-01)

Three aspects of acupuncture-related adverse events: Issues around the reporting of acupuncture-related adverse events
by: Tae-Hun Kim, et al.
Published: (2023-09-01)

Identifying Adverse Events in Outpatients With Prostate Cancer Using Pharmaceutical Care Records in Community Pharmacies: Application of Named Entity Recognition
by: Yuki Yanagisawa, et al.
Published: (2025-03-01)

What to do in the event of an adverse anaesthetic event or medical error
by: Jenny Thomas
Published: (2014-05-01)

Exploring Novel Adverse Events of Nefecon
by: Jingyu Wang, et al.
Published: (2024-09-01)

Neurologic adverse events of cancer immunotherapy
by: Marcelo Houat de Brito
Published: (2022-08-01)

An infrequent but unpleasant adverse event of Tamsulosin
by: Antonio Villa
Published: (2024-04-01)

Correction: Adverse events associated with amlodipine: a pharmacovigilance study using the FDA adverse event reporting system
by: Jiazhen Jiang, et al.
Published: (2025-06-01)

Neurological adverse events associated with baclofen: A disproportionality analysis based on FDA Adverse Event Reporting System
by: Ni Zhang, et al.
Published: (2025-04-01)

Exploration of adverse event profiles for cefotaxime: a disproportionality analysis using the FDA adverse event reporting system
by: Cheng Jiang, et al.
Published: (2025-07-01)

Adverse event profile differences between maribavir and valganciclovir: findings from the FDA adverse event reporting system
by: Haolin Teng, et al.
Published: (2025-05-01)

Neurological adverse events associated with baclofen: a pharmacovigilance study based on FDA adverse event reporting system
by: Yunhan Zhao, et al.
Published: (2025-05-01)

Postmarketing Surveillance of Full Spectrum Hemp Extract CBD Products: Reported Adverse Events and Serious Adverse Events
by: Colleen M. Kingsbury, et al.
Published: (2024-09-01)

Ophthalmic corticosteroids-related adverse events: the FDA adverse event reporting system (FAERS) database pharmacovigilance study
by: Chengzhi Liu, et al.
Published: (2024-12-01)

Adverse event reporting of faricimab: a disproportionality analysis of FDA adverse event reporting system (FAERS) database
by: Chang-Zhu He, et al.
Published: (2025-03-01)

A comprehensive prospective analysis of surgical outcomes and adverse events in spinal procedures among octogenarians: A detailed analysis from a German tertiary center
by: P. Lenga, et al.
Published: (2024-01-01)

Trends in acute care of cerebrovascular events – a joinpoint analysis with German hospital data from 2000 to 2021
by: Richard Schmidt, et al.
Published: (2025-06-01)

Searching for new physics in WW and single-W events
by: Einhaus Ulrich, et al.
Published: (2024-01-01)

CareTrack Kids—part 3. Adverse events in children's healthcare in Australia: study protocol for a retrospective medical record review
by: Sarah Dalton, et al.
Published: (2015-04-01)

Factors associated with adverse events following immunization in Albanian children: An analysis of the national database of adverse events after immunization
by: Irsida Mehmeti, et al.
Published: (2019-03-01)

Safety assessment of laronidase: real-world adverse event analysis based on the FDA adverse event reporting system (FAERS)
by: Zhuomiao Lin, et al.
Published: (2025-08-01)

Neurological adverse events associated with antidepressants: a comprehensive 22-year analysis of the FDA adverse event reporting system
by: Qian Yu, et al.
Published: (2025-08-01)

Disproportionality analysis of upadacitinib-related adverse events in inflammatory bowel disease using the FDA adverse event reporting system
by: Shiyi Wang, et al.
Published: (2025-02-01)

Adverse events associated with herbal medicine products reported in the Korea Adverse Event Reporting System from 2012 to 2021
by: Yujin Choi, et al.
Published: (2024-10-01)

Evaluation of post-market adverse events of lubiprostone: a real-world adverse event analysis from the FAERS database
by: Qingqing Li, et al.
Published: (2025-05-01)